Fish Oil and Selenium Supplement for Radiotherapy Side Effects
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer radiotherapy and chemotherapy protocols often face inefficacy against certain tumor types and are associated with significant side effects, such as nausea, weight loss, and tissue damage, with existing enhancements like gold nanoparticles and COX-2 inhibitors showing selectivity issues and limited effectiveness.
Innovation Solution
A nutritional supplement combining fish oil and selenium is used in conjunction with radiotherapy, providing a synergistic effect that reduces tumor size and mitigates side effects, while modulating genes related to angiogenesis and apoptosis, and preventing metastasis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If radiotherapy and chemotherapy protocols are used to treat cancer, then tumor cells can be targeted and destroyed, but significant side effects occur including nausea, weight loss, hair loss, damage to the gastrointestinal tract, and skin irritation
Solution Approach 1:
The patent uses selenium-enriched yeast as an intermediary substance that mediates between the harmful radiation/chemotherapy and healthy tissues. The yeast acts as a protective agent that reduces side effects while maintaining treatment efficacy, addressing the contradiction by introducing a third component that balances the harmful effects against the therapeutic benefits
Solution Approach 2:
The patent applies selenium supplementation before and during cancer treatment to preemptively counteract the harmful effects of radiotherapy and chemotherapy. By administering selenium-enriched yeast prior to treatment, the body is prepared to resist the anticipated damage, reducing side effects before they fully manifest while allowing the cancer treatment to proceed
2Reliability
If gold nanoparticles or COX-2 inhibitors are used to enhance radiotherapy effectiveness, then tumor cell sensitivity to radiation increases, but selectivity issues arise and effectiveness is limited against certain tumor types
Solution Approach 1:
The patent employs selenium-enriched yeast as a universal enhancement agent that can be applied across multiple tumor types and treatment modalities. Unlike gold nanoparticles or COX-2 inhibitors that target specific pathways, selenium provides broad-spectrum radiosensitization and chemosensitization that works across different cancer types, addressing the versatility limitation while maintaining enhancement effectiveness
3Object-affected harmful factors
If the total radiation dose is partitioned into smaller doses with time intervals for recovery, then side effects are reduced, but treatment effectiveness may be compromised
Solution Approach 1:
Selenium-enriched yeast serves as a protective intermediary that allows maintenance of higher effective radiation doses while reducing harmful side effects. The selenium acts as a buffer that permits more aggressive treatment protocols without proportionally increasing toxicity, resolving the contradiction between dose intensity and side effect management
4Object-affected harmful factors
If chemotherapeutic agents are selected to have reduced toxicity, then side effects are minimized, but effectiveness against tumor cells is reduced
Solution Approach 1:
Selenium-enriched yeast acts as a chemosensitizing intermediary that enhances the effectiveness of less toxic chemotherapeutic agents. The selenium compounds work synergistically with the chemotherapy drugs, allowing lower doses of toxic agents to achieve the same therapeutic effect, or enabling use of milder agents that would otherwise be insufficiently effective
Data Source
AI summary
A nutritional supplement containing fish oil and selenium has been identified that reduces inflammation. A formulation for such a supplement that is both well tolerated and palatable is also provided.